Psoriasis Induced by Trastuzumab (Herceptin®)

Trastuzumab (Herceptin), a humanized monoclonal antibody, is a cancer drug developed to target the human epidermal receptor (HER) 2, which is overexpressed in some cancer cells. Cutaneous side effects, such as folliculitis, xerosis, and alopecia have not been reported with therapies targeting HER2,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kim, Dae Hun, Jeong, Nam Ji, Im, Myung, Lee, Young, Seo, Young Joon, Lee, Jeung Hoon
Format: Artigo
Idioma:Inglês
Publicat: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2013
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3662920/
https://ncbi.nlm.nih.gov/pubmed/23717018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2013.25.2.229
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars